Pfizer Beats Q4 Revenue, EPS Estimates
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Pharmaceuticals giant Pfizer (NYSE:PFE) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts’ consensus estimates. The company reported an adjusted earnings per share of $0.63, significantly above the analyst consensus of $0.47, while gener
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1497891457-d82cfc7b06cf4d47839cc05536833860.jpg "Financial Buzzwords That Defined the Past 25 Years")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1820601093-74f40701ddaa4bc4b185f98f3eb9331f.jpg "<div>I'm a Financial Advisor—Here's 3 Tips to Get Organized for Tax Season</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-948322884-06f9576cc7e5463a97957fdf5ae1b9c1.jpg "Small Business Contract Discrimination")
